Harvest Fund Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-602
| Closed | -$51K | – | 551 |
|
|
2025
Q4 | $51K | Hold |
602
| – | – | ﹤0.01% | 427 |
|
|
2025
Q3 | $47K | Hold |
602
| – | – | ﹤0.01% | 445 |
|
|
2025
Q2 | $47K | Buy |
+602
| New | +$44.9K | ﹤0.01% | 435 |
|
|
2025
Q1 | – | Sell |
-33
| Closed | -$2K | – | 724 |
|
|
2024
Q4 | $2K | Buy |
+33
| New | +$2.31K | ﹤0.01% | 711 |
|
|
2024
Q3 | – | Sell |
-3,184
| Closed | -$294K | – | 650 |
|
|
2024
Q2 | $294K | Sell |
3,184
-8,334
| -72% | -$738K | 0.02% | 298 |
|
|
2024
Q1 | $1.1M | Buy |
11,518
+11,410
| +10,565% | +$958K | 0.1% | 134 |
|
|
2023
Q4 | $8K | Hold |
108
| – | – | ﹤0.01% | 552 |
|
|
2023
Q3 | $7K | Sell |
108
-2,199
| -95% | -$177K | ﹤0.01% | 550 |
|
|
2023
Q2 | $218K | Buy |
2,307
+2,279
| +8,139% | +$198K | 0.04% | 190 |
|
|
2023
Q1 | $2K | Buy |
+28
| New | +$2.2K | ﹤0.01% | 705 |
|
|
2022
Q3 | – | Sell |
-454
| Closed | -$43K | – | 808 |
|
|
2022
Q2 | $43K | Hold |
454
| – | – | 0.01% | 432 |
|
|
2022
Q1 | $53K | Sell |
454
-1,207
| -73% | -$135K | 0.01% | 423 |
|
|
2021
Q4 | $216K | Sell |
1,661
-1,134
| -41% | -$132K | 0.04% | 234 |
|
|
2021
Q3 | $316K | Buy |
2,795
+2,035
| +268% | +$232K | 0.07% | 91 |
|
|
2021
Q2 | $79K | Buy |
760
+173
| +29% | +$16.3K | 0.01% | 323 |
|
|
2021
Q1 | $49K | Hold |
587
| – | – | ﹤0.01% | 415 |
|
|
2020
Q4 | $53K | Buy |
+587
| New | +$48.7K | ﹤0.01% | 347 |
|
|
2020
Q1 | – | Sell |
-3,465
| Closed | -$230K | – | 431 |
|
|
2019
Q4 | $230K | Sell |
3,465
-114
| -3% | -$8.9K | 0.02% | 97 |
|
|
2019
Q3 | $262K | Buy |
3,579
+1,638
| +84% | +$115K | 0.03% | 91 |
|
|
2019
Q2 | $120K | Hold |
1,941
| – | – | 0.01% | 174 |
|
|
2019
Q1 | $124K | Buy |
+1,941
| New | +$111K | 0.02% | 172 |
|
|
2018
Q3 | – | Sell |
-873
| Closed | -$42K | – | 438 |
|
|
2018
Q2 | $42K | Hold |
873
| – | – | 0.01% | 215 |
|
|
2018
Q1 | $40K | Hold |
873
| – | – | 0.01% | 188 |
|
|
2017
Q4 | $33K | Hold |
873
| – | – | 0.01% | 195 |
|
|
2017
Q3 | $32K | Hold |
873
| – | – | ﹤0.01% | 179 |
|
|
2017
Q2 | $34K | Buy |
+873
| New | +$31.9K | ﹤0.01% | 178 |
|
Other funds holding EW
VCM
VPM
Harvest Fund Management's EW Position: Q1 2026 in Review
Harvest Fund Management sold out of Edwards Lifesciences (EW) in Q1 2026, closing a stake of 602 shares — an estimated $51K sold.
Harvest Fund Management first reported a position in EW in Q2 2017 and held it in 26 quarters. The position peaked at $1.1M in Q1 2024. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Harvest Fund Management reported no remaining Edwards Lifesciences position as of Q1 2026 after selling out during the quarter.
- Harvest Fund Management sold 602 Edwards Lifesciences shares in Q1 2026, an estimated $51K.
- Harvest Fund Management first reported a position in Edwards Lifesciences in Q2 2017 and held it in 26 quarters.
- Harvest Fund Management's Edwards Lifesciences position peaked at $1.1M in Q1 2024.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Harvest Fund Management's 13F filing for Q1 2026, filed 14 May 2026.